LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of 3D software and sophisticated 3D printing solutions, and pioneer in medical image based guide technology, today announced the signing of an agreement with the Swiss orthopaedic producer Mathys for the use of Materialise’s Shoulder Guide System.
Hilde Ingelaere, Executive Vice President of Materialise’s Medical Segment, states, “Through our collaboration with Mathys, our goal is to enable even more surgeons to discover the benefits of 3D printing in the planning and execution of total and reverse shoulder replacement surgeries. It is through partnerships like this that we at Materialise continue realizing our mission of developing innovations that result in a better and healthier world. ”
Ronald Lenzeder, Director Marketing of Mathys, said, “Since 1958, Mathys has been committed to offering our clients and their patients the best possible restoration of quality of life. By including Materialise’s Shoulder Guide System in our portfolio, we are able to deliver on this promise by helping surgeons achieve more predictable surgical outcomes through the use of pre-operative planning and 3D printed patient-specific guides.”
The Materialise Shoulder Guide System, a solution consisting of easy-to-use 3D surgical planning software and patient-specific surgical guides for shoulder surgery, allows surgeons to efficiently and accurately plan shoulder surgeries based on the patient’s unique anatomy. Based on that pre-operative plan, patient-specific guides are designed and 3D printed for use during surgery.
With its headquarters in Leuven, Belgium, and branches worldwide, Materialise is a provider of Additive Manufacturing (AM) software solutions and sophisticated 3D printing services in a wide variety of industries, including healthcare, automotive, aerospace, art and design and consumer products. Materialise has been playing an active role in the field of AM since 1990, through its involvement in AM for industrial and medical applications, by providing biomedical and clinical solutions such as medical image processing and surgical simulations and by developing unique solutions for its customers' prototyping, production, and medical needs. For additional information, please visit: www.materialise.com.
About Mathys Ltd Bettlach
Swiss Orthopedics Company Mathys was founded in 1946 and looks back at 58 years of experience in the field of medical technology. Since 1 November 2003 the company has focused exclusively on the development, production and distribution of joint replacement products. At this point in time Mathys supplies hip, knee and shoulder implants and synthetic bone replacement material. In 2013, the company has entered the sports orthopedics market.
Mathys operates 11 subsidiaries in Australia, Austria, Belgium, China, France, Germany, Japan, Netherlands, New Zealand, United Kingdom and Switzerland and is represented by over 30 local marketing partners worldwide. The company is owned by the Mathys and Marzo families, Hugo Mathys is CEO and Chairman of the Board of Directors. With Livio Marzo and Roger Mathys, the 3rd Generation is represented on the Board of Directors.
Cautionary Statement on Forward-Looking Statements
This press release contains forward-looking statements regarding, among other things, the plans, objectives, expectations, strategies and prospects of the Company, both financial and business. Such statements are subject to known and unknown uncertainties and risks. When used in this press release, the words “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “believe,” “forecast,” “will”, “may”, “could”, “might”, “aim”, “should” and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon the management’s current expectations. These expectations, beliefs and projections are given in good faith and management believes there is a reasonable basis for them. However, the management cannot offer any assurance that its expectations, beliefs and projections will actually be achieved. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics and industry change, and depend on economic circumstances that may or may not occur in the future or may occur on longer or shorter timelines than anticipated. Management cautions readers that forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are in some cases beyond its control. All of the forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from expectations. Management makes no commitment, and disclaims any duty to update or revise any forward-looking statements to reflect future events or changes in its expectations.
Materialise Shoulder Guide System is not commercially available with Mathys implants in the United States and Canada.